8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001
2 November 2001. Related: Conference reports.
EACS 8th Athens 2001
HIV drug resistance can develop under HAART at low levels of viraemia
2 November 2001. Related: Conference reports, Drug resistance.
Combinations of lopinavir/r and amprenavir in heavily treatment experienced patients
2 November 2001. Related: Conference reports, PK and drug interactions.
Further reports of benefits of polylactic acid for facial lipoatrophy
2 November 2001. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
GigaHAART study shows benefit of treatment interruption prior to treatment with >7 drugs in highly treatment experienced patients
2 November 2001. Related: Conference reports, Drug resistance.
Tenofovir DF 907 study
2 November 2001. Related: Conference reports, Antiretrovirals.
The Max Cmin 1 trial: indinavir/ritonavir vs. saquinavir/ritonavir
2 November 2001. Related: Conference reports, Antiretrovirals.
No significant drug interactions found between tenofovir DF and indinavir, lopinavir/r, lamivudine, or efavirenz
2 November 2001. Related: Conference reports, PK and drug interactions.
Ritonavir corrects drug interaction between efavirenz and saquinavir
2 November 2001. Related: Conference reports, PK and drug interactions.
Lopinavir/r effective in naive patients after three years of treatment
2 November 2001. Related: Conference reports.